Skip to main content

Table 2 Percent improvement of secondary rating scale scores

From: The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial

  Q+CBT
(N = 11)
P+CBT
(N = 11)
Between group
differences
HADS 20%a 6% ns
CGI-S 33%c 12%a ns
CGI-I 33%c 23%a ns
Q-LES-Q 29%b 2% p < 0.05d
  1. a p < 0.05, t-test for paired values comparing screen (or randomization) and LOCF scores for individual rating scales within each group.
  2. b p < 0.01, t-test for paired values comparing screen and LOCF scores for the Q-LES-Q rating scale within each group.
  3. c p < 0.005, t-test for paired values comparing screen (or randomization) and LOCF scores for individual rating scales within each group.
  4. d ANCOVA using screen scores as covariates and LOCF scores as outcome.